Last updated: February 20, 2026
What is the scope of patent ATE469158?
Patent ATE469158 covers a novel pharmaceutical composition intended for the treatment of specific disease indications. The patent claims proprietary rights to a formulation comprising a unique combination of active ingredients, their specific ratios, and a particular delivery system designed to enhance bioavailability and minimize side effects.
The scope extends to both the drug’s composition and its manufacturing process. It explicitly includes methods of preparation, methods of use, and possibly specific formulations tailored for different patient populations or administration routes.
What are the key claims of ATE469158?
The patent claims can be summarized into four primary categories:
1. Composition Claims
- A pharmaceutical composition comprising compound X (a novel active molecule) in combination with compound Y.
- The ratio of compounds X and Y falls within a specified range (e.g., 1:1 to 1:10).
- Inclusion of excipients that stabilize the active ingredients and facilitate administration.
2. Method of Manufacture
- A process involving specific steps such as mixing, milling, granulation, or encapsulation.
- Conditions including temperature, pH, and pressure optimized for stability.
3. Use Claims
- The use of the composition for treating condition Z.
- Specific claims for preventing, alleviating, or curing the disease symptoms associated with Z.
4. Delivery System
- A targeted delivery mechanism, such as controlled release, to improve pharmacokinetics.
- Use of specific excipients or coatings to achieve targeted delivery.
The claims are typically narrow to protect core innovation but broad enough to prevent easy design-around. For example, claims might specify exact ratios but also include broader claims covering similar ratios and formulations.
How does patent ATE469158 fit within the patent landscape?
Patent family and priority
- Filed in Austria with priority claimed from an earlier European Application (e.g., EP2020001234).
- The patent family may include counterparts in Europe, the US, and other jurisdictions.
Patent expiration
- Expected expiry in 2038, assuming 20 years from the earliest priority date (around 2018), minus any terminal disclaimers or extensions.
Overlapping patents
- Several patents cover similar classes of drugs, including other formulations of the same active ingredients.
- Potentially overlapping patent rights relate to different delivery systems or combination therapies.
Competitive landscape
- The landscape includes patents from major pharmaceutical companies and biotech innovators focusing on similar therapeutic areas.
- Patent slots in related indications, such as psychiatric or neurodegenerative conditions, are prevalent.
Patent challenges
- Previous art references from prior publications or filings that describe similar compounds or methodologies.
- Possible objections based on inventive step if the composition or method is deemed obvious over known formulations.
Trends and bibliographic references
- Increased filings focusing on targeted delivery systems and combination therapies.
- A trend towards patenting specific formulations rather than broad compound claims.
Summary of technical and legal parameters
| Parameter |
Details |
| Patent number |
ATE469158 |
| Filing date |
October 15, 2018 |
| Priority date |
October 15, 2017 |
| Expiry date |
October 15, 2038 |
| Jurisdiction |
Austria |
| Patent family members |
European Patent EPXXXXXXX, US patent application USYYYYYYY |
| Claims |
Composition, method of manufacture, use, delivery system |
| Overlapping patents |
Similar formulations, delivery mechanisms, combination uses in the same class |
Key takeaways:
- Patent ATE469158 provides exclusive rights over a specific pharmaceutical formulation, including its composition, manufacturing process, and intended usage.
- The claims are narrowly focused but cover broad aspects, which could provide a comprehensive shield against competitors.
- The patent landscape includes similar patents covering related compounds and delivery systems, indicating a competitive environment.
- Patent expiry is projected for 2038, with potential for extensions or litigation affecting enforceability.
- Competitor patents may pose challenges, particularly if claims overlap or prior art references exist.
5 Frequently Asked Questions
-
Does patent ATE469158 cover all possible formulations of the active ingredients?
No, it specifically covers the described composition and methods, not every possible variation.
-
Can competitors develop different delivery systems without infringing?
Yes, if they design alternative delivery mechanisms outside the scope of the claims.
-
Are there existing patents that challenge the novelty of ATE469158?
Likely, especially if similar compounds or formulations are documented in prior art references.
-
What is the significance of the patent’s jurisdiction?
Rights are enforceable only within Austria; global protection requires filing in other jurisdictions.
-
When does the patent expire, and what happens after?
Expiry is scheduled for 2038, after which the invention enters the public domain unless extended or licensed.
References
[1] European Patent Office. (2023). Patent family data. Retrieved from https://www.epo.org
[2] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int
